» Articles » PMID: 36756619

Colonized Patients by : Third and Largest Outbreak in Brazil and Impact of Biofilm Formation

Abstract

Objective: To describe the clinical-epidemiological features of patients colonized by in the largest outbreak in Brazil and to show the biofilm formation capacity of yeast strains.

Methods: Clinical yeasts suspected of isolated from urine and surveillance samples were seeded on chromogenic media at 30°C and Sabouraud agar at 42°C. matrix-assisted laser desorption/ionization-time of flight mass spectometry was used for reliable identification. After proteomic confirmation, the genomic approach and culture on Chromagar Plus media were carried out. Biofilm formation was investigated based on metabolic activity, and the clinical-epidemiological profile of patients was described.

Results: A total of 11 C clinical yeasts from nine patients were identified between the end of December 2021 and March 2022. Two clinical yeasts were isolates from urine and nine clinical yeasts were isolates from axillary and inguinal surveillance swabs. No case is related to previous Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, all the yeasts showed a high ability of biofilm formation.

Conclusion: requires great vigilance as its high capacity to colonize and form biofilms contributes to its dissemination. The rapid and precise identification of this species is essential for the management, control, and prevention of infections.

Citing Articles

Surfactant-Driven Effects on the Antifungal Activity of Kunth Essential Oil Encapsulated in Lipid-Based Nanosystems.

Gil G, Kakuda L, Tonani L, von Zeska Kress M, Oliveira W ACS Omega. 2025; 10(8):7876-7887.

PMID: 40060779 PMC: 11886426. DOI: 10.1021/acsomega.4c08578.


Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts.

Almatroudi A Biology (Basel). 2025; 14(2).

PMID: 40001933 PMC: 11852148. DOI: 10.3390/biology14020165.


Enhancing ICU spp. surveillance: a cost-effective approach focused on detection.

Nascimento T, Inacio J, Guerreiro D, Diaz P, Patricio P, Proenca L Front Cell Infect Microbiol. 2024; 14:1463456.

PMID: 39554808 PMC: 11564180. DOI: 10.3389/fcimb.2024.1463456.


Unmasking the Antifungal Activity of Leaf Extract against .

Quejada L, Hernandez A, Chitiva L, Bravo-Chaucanes C, Vargas-Casanova Y, Faria R J Fungi (Basel). 2024; 10(7).

PMID: 39057348 PMC: 11277670. DOI: 10.3390/jof10070464.


Screening of Candida spp. in wastewater in Brazil during COVID-19 pandemic: workflow for monitoring fungal pathogens.

Correa-Moreira D, da Costa G, de Lima Neto R, Pinto T, Salomao B, Fumian T BMC Biotechnol. 2024; 24(1):43.

PMID: 38909197 PMC: 11193224. DOI: 10.1186/s12896-024-00868-z.


References
1.
Pierce C, Uppuluri P, Tristan A, Wormley Jr F, Mowat E, Ramage G . A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008; 3(9):1494-500. PMC: 2741160. DOI: 10.1038/nport.2008.141. View

2.
Lockhart S, Etienne K, Vallabhaneni S, Farooqi J, Chowdhary A, Govender N . Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2016; 64(2):134-140. PMC: 5215215. DOI: 10.1093/cid/ciw691. View

3.
Aldejohann A, Wiese-Posselt M, Gastmeier P, Kurzai O . Expert recommendations for prevention and management of Candida auris transmission. Mycoses. 2022; 65(6):590-598. DOI: 10.1111/myc.13445. View

4.
Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R . Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?. J Clin Microbiol. 2016; 55(2):638-640. PMC: 5277535. DOI: 10.1128/JCM.02202-16. View

5.
Saitou N, Nei M . The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4):406-25. DOI: 10.1093/oxfordjournals.molbev.a040454. View